Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 3.1B | 2.8B | 2.6B |
Cost of revenue | 1.2B | 1.2B | 1.1B | 1.0B |
Gross profit | 1.9B | 1.9B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | 338.0M | 346.2M | 323.1M | 325.8M |
Selling general and admin | 248.9M | 267.1M | 251.0M | 255.1M |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.2B | 1.1B | 977.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 71.9M | 75.0M | 82.2M | 82.8M |
Other income expense | 35.9M | -194.6M | 40.9M | -110.1M |
Pretax income | 1.3B | 972.5M | 1.1B | 945.0M |
Tax provision | 176.0M | 148.0M | 132.8M | 108.6M |
Net income | 1.1B | 824.5M | 945.9M | 836.4M |
Basic EPS | 8.2 | 6.2 | 7.1 | 6.2 |
Diluted EPS | 8.2 | 6.2 | 7.0 | 6.2 |
Basic average shares | 132.6M | 133.3M | 134.1M | 134.5M |
Diluted average shares | 133.3M | 133.9M | 134.9M | 135.3M |
EBITDA | 1.4B | 1.4B | 1.3B | 1.1B |
Net income from continuing op. | 1.1B | 824.5M | 945.9M | 836.4M |
Minority interests | — | — | — | 0 |
Preferred stock dividends | — | — | — | — |